Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 57

1.

Behavior therapy for pediatric trichotillomania: Exploring the effects of age on treatment outcome.

Franklin ME, Edson AL, Freeman JB.

Child Adolesc Psychiatry Ment Health. 2010 Jun 28;4:18. doi: 10.1186/1753-2000-4-18.

2.
3.

Nonsomatic treatment of depression.

Sherrill JT, Kovacs M.

Child Adolesc Psychiatr Clin N Am. 2002 Jul;11(3):579-93. Review.

PMID:
12222084
4.
5.

A randomised controlled trial of cognitive behaviour therapy in adolescents with major depression treated by selective serotonin reuptake inhibitors. The ADAPT trial.

Goodyer IM, Dubicka B, Wilkinson P, Kelvin R, Roberts C, Byford S, Breen S, Ford C, Barrett B, Leech A, Rothwell J, White L, Harrington R.

Health Technol Assess. 2008 May;12(14):iii-iv, ix-60.

6.

Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years.

Knorr B, Franchi LM, Bisgaard H, Vermeulen JH, LeSouef P, Santanello N, Michele TM, Reiss TF, Nguyen HH, Bratton DL.

Pediatrics. 2001 Sep;108(3):E48.

PMID:
11533366
7.

[Atomoxetine: a new treatment for Attention Deficit/Hyperactivity Disorder (ADHD) in children and adolescents].

Purper-Ouakil D, Fourneret P, Wohl M, Rénéric JP.

Encephale. 2005 May-Jun;31(3):337-48. Review. French.

PMID:
16142049
8.
9.

N-acetylcysteine, a glutamate modulator, in the treatment of trichotillomania: a double-blind, placebo-controlled study.

Grant JE, Odlaug BL, Kim SW.

Arch Gen Psychiatry. 2009 Jul;66(7):756-63. doi: 10.1001/archgenpsychiatry.2009.60.

PMID:
19581567
10.

Effects of budesonide inhalation suspension compared with cromolyn sodium nebulizer solution on health status and caregiver quality of life in childhood asthma.

Murphy KR, Fitzpatrick S, Cruz-Rivera M, Miller CJ, Parasuraman B.

Pediatrics. 2003 Sep;112(3 Pt 1):e212-9.

PMID:
12949315
12.

A placebo-controlled trial of cognitive-behavioral therapy and clomipramine in trichotillomania.

Ninan PT, Rothbaum BO, Marsteller FA, Knight BT, Eccard MB.

J Clin Psychiatry. 2000 Jan;61(1):47-50.

PMID:
10695646
13.
14.

Long-term outcome of cognitive behaviour therapy clinical trials in central Scotland.

Durham RC, Chambers JA, Power KG, Sharp DM, Macdonald RR, Major KA, Dow MG, Gumley AI.

Health Technol Assess. 2005 Nov;9(42):1-174. Review.

15.

Acute atomoxetine treatment of younger and older children with ADHD: a meta-analysis of tolerability and efficacy.

Kratochvil CJ, Milton DR, Vaughan BS, Greenhill LL.

Child Adolesc Psychiatry Ment Health. 2008 Sep 15;2(1):25. doi: 10.1186/1753-2000-2-25.

16.

Treatment of trichotillomania with behavioral therapy or fluoxetine: a randomized, waiting-list controlled study.

van Minnen A, Hoogduin KA, Keijsers GP, Hellenbrand I, Hendriks GJ.

Arch Gen Psychiatry. 2003 May;60(5):517-22.

PMID:
12742873
17.

Dronabinol, a cannabinoid agonist, reduces hair pulling in trichotillomania: a pilot study.

Grant JE, Odlaug BL, Chamberlain SR, Kim SW.

Psychopharmacology (Berl). 2011 Dec;218(3):493-502. doi: 10.1007/s00213-011-2347-8.

PMID:
21590520
18.

Effects of intravenous secretin on language and behavior of children with autism and gastrointestinal symptoms: a single-blinded, open-label pilot study.

Lightdale JR, Hayer C, Duer A, Lind-White C, Jenkins S, Siegel B, Elliott GR, Heyman MB.

Pediatrics. 2001 Nov;108(5):E90.

PMID:
11694674
19.

Behavior therapy for pediatric trichotillomania: a randomized controlled trial.

Franklin ME, Edson AL, Ledley DA, Cahill SP.

J Am Acad Child Adolesc Psychiatry. 2011 Aug;50(8):763-71. doi: 10.1016/j.jaac.2011.05.009.

Items per page

Supplemental Content

Support Center